Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 19 citing articles:

Pharmacophore modeling and QSAR analysis of anti-HBV flavonols
Basireh Baei, Parnia Askari, Fatemeh Sana Askari, et al.
PLoS ONE (2025) Vol. 20, Iss. 1, pp. e0316765-e0316765
Open Access | Times Cited: 3
The progress of molecules and strategies for the treatment of HBV infection
Youlu Pan, Heye Xia, Yanwen He, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 25
Immune response and treatment targets of chronic hepatitis B virus infection: innate and adaptive immunity
Peiyu Zheng, Yong‐Qing Dou, Qinying Wang
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 25
Hepatitis B core-related antigen: A novel and promising surrogate biomarker to guide anti-hepatitis B virus therapy
Takako Inoue, Takehisa Watanabe, Yasuhito Tanaka
Clinical and Molecular Hepatology (2023) Vol. 29, Iss. 4, pp. 851-868
Open Access | Times Cited: 24
Chronic Hepatitis B Virus Persistence: Mechanisms and Insights
Srivatsava Naidu, Séverine Margeridon
Cureus (2025)
Open Access | Times Cited: 1
Novel mechanistic insights – A brand new Era for anti-HBV drugs
Weiping Lyu, Haoming Qin, Qi Li, et al.
European Journal of Medicinal Chemistry (2024) Vol. 279, pp. 116854-116854
Closed Access | Times Cited: 4
Targeting hepatitis B virus cccDNA levels: Recent progress in seeking small molecule drug candidates
Yu Jin, Shuo Wang, Shujing Xu, et al.
Drug Discovery Today (2023) Vol. 28, Iss. 7, pp. 103617-103617
Open Access | Times Cited: 11
Small Extracellular Vesicles Promote HBV Replication via METTL3–IGF2BP2-Mediated m6A Modification
Jie Zhang, Ling Yu, Xinyu Wu, et al.
Frontiers in Bioscience-Landmark (2025) Vol. 30, Iss. 3
Open Access
D-Cycloserine, a potential candidate for reducing hepatitis B virus cccDNA in vitro
Yongwook Choi, Yong Kwang Park, Wonhee Hur, et al.
Journal of Virological Methods (2025), pp. 115172-115172
Closed Access
The Intrinsically Disordered Region of HBx and Virus–Host Interactions: Uncovering New Therapeutic Approaches for HBV and Cancer
Rodrigo A. Villanueva, Alejandra Loyola
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 8, pp. 3552-3552
Open Access
Two Concepts of Hepatitis B Core-Related Antigen Assay: A Highly Sensitive and Rapid Assay or an Effective Tool for Widespread Screening
Takako Inoue, Shintaro Yagi, Yasuhito Tanaka
Viruses (2024) Vol. 16, Iss. 6, pp. 848-848
Open Access | Times Cited: 2
Mechanistic insights of clinically proven natural products in the treatment of hepatitis B focusing on clinical evidence and pathways
Anwar Parvez, Anand Kumar Das, Ashik Mahmud, et al.
Deleted Journal (2024), pp. 200183-200183
Open Access | Times Cited: 2
Novel non-HAP class A HBV capsid assembly modulators have distinct in vitro and in vivo profiles
Hannah Vanrusselt, Dieudonné Buh Kum, Valério Taverniti, et al.
Journal of Virology (2023) Vol. 97, Iss. 10
Open Access | Times Cited: 5
Forthcoming Developments in Models to Study the Hepatitis B Virus Replication Cycle, Pathogenesis, and Pharmacological Advancements
Sajad Ahmad Bhat, Ishfaq Ahmad Ahanger, Syed Naqui Kazim
ACS Omega (2023) Vol. 8, Iss. 16, pp. 14273-14289
Open Access | Times Cited: 4
A road to contemporary era of hepatitis B virus regimen replacing existing therapeutics exploiting plant secondary metabolites as emerging heroes in exploring drugs: An expedition for a functional cure
Sajad Ahmad Bhat, Syed Naqui Kazim
Gene Reports (2023) Vol. 30, pp. 101743-101743
Closed Access | Times Cited: 2
A Current Management Strategy for Children with Chronic Viral Hepatitis B, Based on International and National Guidelines.
Інна Миколаївна Несіна, Т.O. Kryuchko, О.А. Пода, et al.
PubMed (2023) Vol. 27, Iss. 1, pp. 134-141
Closed Access | Times Cited: 2
CRISPR-Cas based genome editing for eradication of human viruses
Dharmisha Solanki, Karan Murjani, Vijai Singh
Progress in molecular biology and translational science (2024), pp. 43-58
Closed Access
Chronic Hepatitis B Genotype C Mouse Model with Persistent Covalently Closed Circular DNA
Deok-Hwa Seo, Wonhee Hur, Juhee Won, et al.
Viruses (2024) Vol. 16, Iss. 12, pp. 1890-1890
Open Access
Application and Research Progress of Re-al-Time Fluorescence Quantitative PCR and Digital PCR Techniques in Virus Detection
金林 王
Medical Diagnosis (2023) Vol. 13, Iss. 03, pp. 320-327
Closed Access
Page 1

Scroll to top